Stockscreener 앱 받기
1.98
0.51%
0.01
시간 외 거래:
1.99
0.01
+0.51%
전일 마감가:
$1.97
열려 있는:
$1.96
하루 거래량:
697.32K
Relative Volume:
2.12
시가총액:
$103.89M
수익:
$21.05M
순이익/손실:
$-89.22M
주가수익비율:
-1.1061
EPS:
-1.79
순현금흐름:
$-64.50M
1주 성능:
-5.26%
1개월 성능:
+5.32%
6개월 성능:
+67.80%
1년 성능:
-64.58%
1일 변동 폭
$1.93
$2.03
1주일 범위
$1.90
$2.30
52주 변동 폭
$1.02
$6.225
Tscan Therapeutics Inc Stock (TCRX) Company Profile
명칭
Tscan Therapeutics Inc
전화
857-399-9500
주소
830 WINTER STREET, WALTHAM
TCRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TCRX
Tscan Therapeutics Inc
|
1.98 | 111.79M | 21.05M | -89.22M | -64.50M | -1.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Tscan Therapeutics Inc Stock (TCRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-16 | 개시 | BTIG Research | Buy |
| 2024-05-13 | 개시 | Needham | Buy |
| 2023-06-22 | 개시 | Wedbush | Outperform |
Tscan Therapeutics Inc 주식(TCRX)의 최신 뉴스
How to forecast TScan Therapeutics Inc. trends using time seriesWall Street Watch & Long-Term Capital Growth Strategies - newser.com
Short interest data insights for TScan Therapeutics Inc.2025 Macro Impact & Low Drawdown Investment Strategies - newser.com
TScan Therapeutics Inc. stock daily chart insightsJuly 2025 Intraday Action & Capital Efficient Trading Techniques - newser.com
Will TScan Therapeutics Inc. stock maintain momentum in 2025Portfolio Profit Report & AI Based Buy/Sell Signal Reports - newser.com
Will TScan Therapeutics Inc. stock continue dividend increasesWeekly Profit Recap & Free Long-Term Investment Growth Plans - newser.com
What the charts say about TScan Therapeutics Inc. today2025 Winners & Losers & AI Driven Stock Reports - newser.com
Is TScan Therapeutics Inc a good long term investmentSwing Trading Ideas & Fast Growing Capital Growth - earlytimes.in
Goldman Sachs Group Inc. Buys 9,676 Shares of TScan Therapeutics, Inc. $TCRX - Defense World
H.C. Wainwright Maintains TScan Therapeutics(TCRX.US) With Buy Rating, Maintains Target Price $10 - 富途牛牛
Risk adjusted return profile for TScan Therapeutics Inc. analyzedTrade Performance Summary & Growth Focused Entry Point Reports - newser.com
TScan Therapeutics, Inc. (NASDAQ:TCRX) Receives Consensus Rating of “Buy” from Analysts - Defense World
Brokerages Set TScan Therapeutics, Inc. (NASDAQ:TCRX) PT at $7.80 - MarketBeat
How to build a custom watchlist for TScan Therapeutics Inc.July 2025 Opening Moves & Advanced Technical Signal Analysis - newser.com
Energy Moves: Will TScan Therapeutics Inc benefit from seasonalityDip Buying & Fast Entry Momentum Trade Alerts - خودرو بانک
Tscan Therapeutics Inc (TCRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.05%
4.71%
자본화:
|
볼륨(24시간):